Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial (Q34607209)

3 August 2017

title

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial (English)

1 reference

3 August 2017

Scott D Berkowitz

9

0 references

author name string

Alexander G G Turpie

1

1 reference

3 August 2017

Michael R Lassen

2

1 reference

3 August 2017

Bruce L Davidson

3

1 reference

3 August 2017

Kenneth A Bauer

4

1 reference

3 August 2017

Michael Gent

5

1 reference

3 August 2017

Louis M Kwong

6

1 reference

3 August 2017

Fred D Cushner

7

1 reference

3 August 2017

Paul A Lotke

8

1 reference

3 August 2017

Tiemo J Bandel

10

1 reference

3 August 2017

Alice Benson

11

1 reference

3 August 2017

Frank Misselwitz

12

1 reference

3 August 2017

William D Fisher

13

1 reference

3 August 2017

RECORD4 Investigators

14

1 reference

3 August 2017

language of work or name

English

0 references

publication date

4 May 2009

1 reference

3 August 2017

1 reference

3 August 2017

volume

373

1 reference

3 August 2017

issue

9676

1 reference

3 August 2017

page(s)

1673-1680

1 reference

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Roentgen diagnosis of venous thrombosis in the leg

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960734-0

7 January 2021

10.1016/S0140-6736(09)60734-0

Identifiers

DOI

1 reference

3 August 2017

1 reference